Facteurs de risque de l’utilisation de l’érythromycine comme agent prokinétique

作者: S. Berthet , B. Charpiat , J.Y. Mabrut

DOI: 10.1016/J.JCHIRV.2010.06.001

关键词: Surgery

摘要: Resume L’erythromycine est un antibiotique doue de proprietes prokinetiques. Ces sont utilisees en pratique clinique pour accelerer la vidange gastrique, notamment chez les patients presentant une gastroparesie. Cependant, parmi nombreuses etudes realisees dans cette indication, rares celles bien conduites methodologiquement et evaluant des criteres cliniques. Leurs resultats parfois contradictoires. Le rapport benefice–risque prescription doit integrer gestion interactions medicamenteuses que presente ce principe actif, ainsi prevention du risque cardiovasculaire, torsade pointe l’arret cardiaque. L’objet mise au point presenter donnees recemment publiees sur risques eclairer prescription. La ces necessite communication efficace entre chirurgiens, anesthesistes pharmaciens.

参考文章(46)
J P Méry, A Kanfer, G Stamatakis, G Fredj, S Kenouch, J C Torlotin, Changes in erythromycin pharmacokinetics induced by renal failure. Clinical Nephrology. ,vol. 27, pp. 147- 150 ,(1987)
J M McGUIRE, R C Anderson, H M Powell, R L Bunch, E H Flynn, J W Smith, H E Boaz, Ilotycin, a new antibiotic. Antibiotics and Chemotherapy. ,vol. 2, pp. 281- 283 ,(1952)
Wayne A. Ray, Katherine T. Murray, Sarah Meredith, Sukumar Suguna Narasimhulu, Kathi Hall, C. Michael Stein, Oral erythromycin and the risk of sudden death from cardiac causes The New England Journal of Medicine. ,vol. 351, pp. 1089- 1096 ,(2004) , 10.1056/NEJMOA040582
Jan Tack, Jozef Janssens, Gaston Vantrappen, Theo Peeters, Vito Annese, Inge Depoortere, Eric Muls, Roger Bouillon, Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology. ,vol. 103, pp. 72- 79 ,(1992) , 10.1016/0016-5085(92)91097-N
Fabrizio De Ponti, Elisabetta Poluzzi, Alberto Vaccheri, Ulf Bergman, Lars Bjerrum, John Ferguson, Kerry J. Frenz, Peter McManus, Ingrid Schubert, Gisbert Selke, Georgia Terzis-Vaslamatzis, Nicola Montanaro, Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries. British Journal of Clinical Pharmacology. ,vol. 54, pp. 171- 177 ,(2002) , 10.1046/J.1365-2125.2002.01617.X
Marc A. Ritz, Marianne J. Chapman, Robert J. Fraser, Mark E. Finnis, Ross N. Butler, Patricia Cmielewski, Geoffrey P. Davidson, Deborah Rea, Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill Intensive Care Medicine. ,vol. 31, pp. 949- 954 ,(2005) , 10.1007/S00134-005-2663-8
Heleen van der Sijs, Ravi Kowlesar, A. Peter J. Klootwijk, Stefan P. Nelwan, Arnold G. Vulto, Teun van Gelder, Clinically relevant QTc prolongation due to overridden drug–drug interaction alerts: a retrospective cohort study British Journal of Clinical Pharmacology. ,vol. 67, pp. 347- 354 ,(2009) , 10.1111/J.1365-2125.2008.03357.X
Toshiaki Okudaira, Tsutomu Kotegawa, Hiromitsu Imai, Kimiko Tsutsumi, Shigeyuki Nakano, Kyoichi Ohashi, Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans. The Journal of Clinical Pharmacology. ,vol. 47, pp. 871- 876 ,(2007) , 10.1177/0091270007302562
Bruno Charpiat, Benoit Allenet, Renaud Roubille, Laurence Escofier, Pierrick Bedouch, Michel Juste, François-Xavier Rose, Ornella Conort, Facteurs à prendre en considération pour la gestion des interactions médicamenteuses en pratique clinique Presse Medicale. ,vol. 37, pp. 654- 664 ,(2008) , 10.1016/J.LPM.2007.08.012
Charles J. Yeo, M. Kevin Barry, Patricia K. Sauter, Samuel Sostre, Keith D. Lillemoe, Henry A. Pitt, John L. Cameron, Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Annals of Surgery. ,vol. 218, pp. 229- 238 ,(1993) , 10.1097/00000658-199309000-00002